Literature DB >> 16791117

Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi sarcoma.

Isabelle C Widmer1, Peter Erb, Heini Grob, Peter Itin, Michele Baumann, Aline Stalder, Rainer Weber, Gieri Cathomas.   

Abstract

OBJECTIVES: Two main routes of human herpesvirus 8 (HHV-8) transmission are known: sexual, predominantly in men who have sex with men; and nonsexual, in endemic populations. Both routes implicate saliva, so identifying the factors that influence oral HHV-8 shedding is important.
METHODS: Using polymerase chain reaction and immunohistochemistry, we prospectively analyzed HHV-8 infection of oral epithelial cells in 98 Swiss HIV Cohort Study patients, with mean follow-up of 9.4 years, and correlated data to immune status, HHV-8 serology, and Kaposi sarcoma (KS) history, as well as survival.
RESULTS: Sixty-eight (43.9%) of the 98 men were HHV-8 seropositive, and 33 (33.67%) had a history of KS. In both groups, men who have sex with men were significantly more affected than heterosexuals (P < 0.05). Of 77 patients, 9 (11.6%) were oral HHV-8 polymerase chain reaction positive, and 2 of these were also positive by immunohistochemistry. Oral HHV-8 detection was not influenced by the immune status, but a trend toward higher detection was observed in patients with KS (P = 0.084). Oral HHV-8 shedding had no predictive value either for the development of KS lesions or for survival.
CONCLUSIONS: Human herpesvirus 8 can be present in oral epithelial cells and is shed independent of the patient's immune status, indicating that oral HHV-8 shedding may occur at any time in HHV-8-seropositive individuals.

Entities:  

Mesh:

Year:  2006        PMID: 16791117     DOI: 10.1097/01.qai.0000226790.31463.e6

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

Review 1.  Saliva as a diagnostic fluid.

Authors:  Daniel Malamud
Journal:  Dent Clin North Am       Date:  2011-01

2.  The herpes simplex virus 1 UL51 protein interacts with the UL7 protein and plays a role in its recruitment into the virion.

Authors:  Richard J Roller; Rachel Fetters
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

3.  Early childhood infection of Kaposi's sarcoma-associated herpesvirus in Zambian households: a molecular analysis.

Authors:  Landon N Olp; Danielle M Shea; Maxine K White; Clement Gondwe; Chipepo Kankasa; Charles Wood
Journal:  Int J Cancer       Date:  2012-08-20       Impact factor: 7.396

Review 4.  [Humanes herpesvirus 8 (HHV-8) and Kaposi sarcoma].

Authors:  C Lebbé
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

5.  Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.

Authors:  Jessica A Kahn; Bret J Rudy; Jiahong Xu; Bill Kapogiannis; Elizabeth Secord; Maura Gillison
Journal:  J Med Virol       Date:  2016-05-09       Impact factor: 2.327

6.  Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons.

Authors:  Rachel A Bender Ignacio; Jason D Goldman; Amalia S Magaret; Stacy Selke; Meei-Li Huang; Soren Gantt; Christine Johnston; Warren T Phipps; Joshua T Schiffer; Richard A Zuckerman; R Scott McClelland; Connie Celum; Larry Corey; Anna Wald; Corey Casper
Journal:  Infect Agent Cancer       Date:  2016-02-10       Impact factor: 2.965

7.  Prospective study of human herpesvirus 8 oral shedding, viremia, and serological status among human immunodeficiency virus seropositive and seronegative individuals in Sao Paulo, Brazil.

Authors:  Paulo H Braz-Silva; Tania R Tozetto-Mendoza; Laura M Sumita; Wilton Freire; Michelle Palmieri; Alan M do Canto; Vivian I Avelino-Silva; Marina Gallottini; Philippe Mayaud; Claudio S Pannuti
Journal:  J Oral Microbiol       Date:  2017-10-15       Impact factor: 5.474

8.  Human Immunodeficiency Virus-Associated Exosomes Promote Kaposi's Sarcoma-Associated Herpesvirus Infection via the Epidermal Growth Factor Receptor.

Authors:  Lechuang Chen; Zhimin Feng; Guoxiang Yuan; Corey C Emerson; Phoebe L Stewart; Fengchun Ye; Ge Jin
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.